A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
Latest Information Update: 07 Jun 2022
At a glance
- Drugs Opiranserin (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Vivozon
- 22 Jul 2020 Status changed from not yet recruiting to recruiting.
- 16 Jun 2020 New trial record